Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

Clinical trial NCT07530770 · RECRUITING

Trial details

NCT number: NCT07530770
Sponsor: Qianfoshan Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Allergic Bronchopulmonary Aspergillosis Severe Asthma ABPA

Start date: 2025-09-01
Primary completion: 2026-07-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.